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        Introduction 
  The Rho family of small GTPases acts as molecular switches 
for a variety of extracellular signals (  Hall, 1998  ). These sig-
nals are transduced through a rapid reorganization of the actin 
cytoskeleton that changes the cell shape, leading to cell adhe-
sion and locomotion (  Ridley et al., 1992  ). Rho GTPases are 
also implicated in many other cellular events and functions 
such as cell polarity, gene transcription, cell cycle progression 
in the G1 phase, microtubule dynamics, vesicular transport, 
and enzymatic processes (  Kozma et al., 1996  ;   Van Aelst and 
D ’ Souza-Schorey,  1997 ;   Aspenstr ö m,  1999 ;   Etienne-Manneville 
and Hall, 2002  ). The Rho family proteins such as Rac1 and 
cdc42 along with proteins like Wiskott-Aldrich syndrome pro-
tein (WASP), neural WASP, and Scar/WAVE participate in cell 
migration, neurite extension, and budding in yeast (  Innocenti 
et al., 2004  ). These proteins can bind to the globular actin and 
Arp2/3 complex through their catalytic domain, which results 
in fi  lament branching at the membrane (  Takenawa and Miki, 
2001  ). The regulatory actions of WASP and neural WASP pro-
teins involve their binding to active cdc42 at their GTPase-
binding domain (  Higgs and Pollard, 2000  ;   Takenawa and 
Miki, 2001  ). WAVE1 was found to be inactive in a complex 
with Nap1, Abi2, PIR121, and HSP300, and a GTP-loaded ac-
tive Rac1 dissociated from this complex, relieving active 
WAVE1-HSP300 (  Eden et al., 2002  ). In contrast, WAVE2 was 
found to bind to active Rac1 indirectly through insulin recep-
tor substrate (IRS) p53 (  Miki et al., 2000  ;   Miki and Takenawa, 
2002  ), a well-characterized adapter protein that connects 
actin remodeling proteins with the Rho family of small GTPases 
(  Funato et al., 2004  ). IRSp53 contains several domains: a 
Rac1-binding domain in the N terminus, a half cdc42/Rac1 
interactive binding (CRIB) motif, a proline-rich domain, and 
an Src homology 3 (SH3) domain. It also binds to cdc42 via 
the CRIB motif and stimulates the formation of fi  lopodia 
through Mena (  Govind et al., 2001  ;   Krugmann et al., 2001  ). 
IRSp53 is involved in neuronal morphogenesis through a va-
riety of proteins (  Soltau et al., 2002  ,   2004  ;   Choi et al., 2005  ; 
  Hori et al., 2005  ). 
  During a comprehensive analysis of loss of heterozygos-
ity in renal cell carcinoma patients, Kank, a kidney ankyrin 
repeat – containing  protein,  was  identifi  ed as a growth suppres-
sor in HEK293 cells and a disruptor of     -actin distribution in 
G-402 cells (  Sarkar et al., 2002  ;   Rodley et al., 2003  ). The pro-
tein contains a coiled-coil domain in the N-terminal region and 
an ankyrin repeat domain in the C-terminal region, both of 
which are likely to be involved in protein  –  protein interactions 
and thus may play a major role in cellular events. Interestingly, 
an orthologue of Kank in   Caenorhabditis elegans ,  VAB-19, 
was reported to act in epidermal morphogenesis and to play a 
  I
n this study, insulin receptor substrate (IRS) p53 is iden-
tiﬁ  ed as a binding partner for Kank, a kidney ankyrin 
repeat  –  containing protein that functions to suppress cell 
proliferation and regulate the actin cytoskeleton. Kank 
speciﬁ  cally inhibits the binding of IRSp53 with active Rac1 
(Rac1 
G12V  ) but not Cdc42 (cdc42 
G12V  ) and thus inhibits the 
IRSp53-dependent development of lamellipodia without 
affecting the formation of ﬁ  lopodia. Knockdown (KD) of 
Kank by RNA interference results in increased lamellipo-
dial development, whereas KD of both Kank and IRSp53 
has little effect. Moreover, insulin-induced membrane ruf-
ﬂ  ing is inhibited by overexpression of Kank. Kank also 
suppresses integrin-dependent cell spreading and IRSp53-
induced neurite outgrowth. Our results demonstrate that 
Kank negatively regulates the formation of lamellipodia 
by inhibiting the interaction between Rac1 and IRSp53.
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IRSp53. Kank inhibits the formation of lamellipodia and 
membrane ruffl  es induced by active Rac1 in NIH3T3 cells. 
In addition, the depletion of Kank induced lamellipodial mem-
brane protrusions in NIH3T3 cells. Furthermore, Kank in-
hibits IRSp53-induced cell spreading and neurite outgrowth in 
N1E115 cells. 
signifi  cant role in the regulation of the actin cytoskeleton (  Ding 
et al., 2003  ). 
  In this study, we report that Kank disrupts the function 
of active Rac1 through IRSp53. The binding between IRSp53 
and Kank inhibits the association of active Rac1 with 
IRSp53 rather than the association of active cdc42 with 
  Figure 1.       Kank interacts and is partially colocalized 
with IRSp53 in vivo.   (A) Coimmunoprecipitation of Kank 
and IRSp53 in VMRC-RCW cells. Approximately 600   μ  g of 
total protein lysate (shown on the right) was used for 
immunoprecipitation (IP) with a preimmune serum or with a 
polyclonal antibody against Kank or IRSp53. The proteins 
in the immunoprecipitates were detected by Western blot-
ting (WB; arrowheads). (B) Immunostaining of Kank and 
IRSp53 in VMRC-RCW cells. Confocal laser microscopic 
images were obtained for Kank (green) and IRSp53 (red) 
using anti-Kank (monoclonal) and anti-IRSp53 (polyclonal) 
antibodies, respectively, and their colocalization at the cell 
periphery (arrowheads) is shown in yellow. (C) Immuno-
staining of Kank and WAVE2 in VMRC-RCW cells. Con-
focal laser microscopic images were obtained for Kank 
(green) and WAVE2 (red) using anti-Kank (polyclonal) or 
anti-WAVE2 (goat polyclonal) antibodies, respectively, 
and their colocalization at the cell periphery (arrowheads) 
is shown in a merged image (yellow). (D) Fractionation of 
HeLa cells. The proteins in the membrane and cytosolic 
fractions were separated, and those indicated were de-
tected by Western blotting. EGF receptor is a marker for 
the membrane, and     -actin and     -tubulin are markers for 
the cytosol. Bars, 10   μ  m.     255 KANK IN ACTIN REMODELING   • Roy et al. 
tween Kank and IRSp53. Immunocytochemical characteriza-
tion of Kank in VMRC-RCW cells, a renal cell carcinoma cell 
line, also showed the colocalization of endogenous Kank and 
IRSp53 at the cell periphery (  Fig. 1 B  , arrowheads). To further 
authenticate our fi   nding, we coimmunostained Kank with 
WAVE2, which is known to be localized to areas of ruffl  ing, in 
VMRC-RCW cells. Kank and WAVE2 were colocalized at the 
cell periphery (  Fig. 1 C  , arrowheads). Furthermore, Kank and 
IRSp53 were both present in the membrane fraction (  Fig. 1 D  ). 
In the spreading cells, IRSp53 was detected at the tips of both 
the lamellipodium and the fi  lopodium (  Nakagawa et al., 2003  ) 
where WAVE2 is also localized (  Miki et al., 2000  ). Thus, we 
concluded that Kank is localized at the leading edge in the 
VMRC-RCW cells. 
  To determine the binding domains of Kank and IRSp53, 
various mutants were constructed for IRSp53 (in GFP-tagged 
forms;   Fig. 2 A  ) and Kank (in Flag-tagged forms;   Fig. 2 C  ). 
HEK293T cells were transfected with the indicated constructs 
along with the wild-type Flag-Kank, and immunoprecipitation 
  Results 
  Kank interacts with IRSp53 in vivo 
  To identify proteins binding to Kank, we screened a human pla-
cental cDNA library using Kank (amino acids 77  –  977) as bait 
with the yeast two-hybrid system. Among   >  200 clones isolated, 
two encoded IRSp53, both lacking 49 amino acids from the 
N terminus. The specifi  city of interaction was confi  rmed by the 
growth of the yeast clones on plates lacking Leu/Trp/His and by 
    -galactosidase activity in the X-gal fi  lter assay (unpublished 
data). To verify the result of the screening, reciprocal coimmuno-
precipitation experiments were performed using antibodies 
against Kank and IRSp53 with mammalian cell lysates ( Fig. 1 A ). 
Immunoprecipitation of Kank resulted in the coprecipitation of 
IRSp53 as detected by Western blotting using the anti-IRSp53 
antibody, whereas the result of the control experiment using a 
preimmune serum was negative. However, immunoprecipita-
tion of IRSp53 resulted in coprecipitation of Kank as detected 
with the anti-Kank antibody, confi  rming binding in vivo be-
  Figure 2.       Kank interacts with IRSp53 through 
their coiled-coil domains.   (A) GFP-tagged 
constructs of IRSp53 used in this study and 
the results of binding to Kank. (B) Interaction 
of IRSp53 with Kank through its coiled-coil 
domain. The vectors expressing Flag-Kank 
and GFP-tagged constructs (constructs a  –  d in A) 
of IRSp53 were transfected in HEK293T cells, 
and the complex containing Kank was immuno-
precipitated with an anti-Flag antibody and 
analyzed by Western blotting using an anti-
Kank antibody (top) or an anti-GFP anti  body 
(indicated by dots; bottom). The GFP expres-
sion vector was used as a control (v), and 
the lysate lanes show the expression of each 
plasmid construct (bottom). (C) Flag-tagged 
and GFP-tagged Kank constructs used in this 
study and the results of binding to IRSp53. 
(D) Interaction of Kank with IRSp53 through 
its coiled-coil domain. The vectors expressing 
GFP-IRSp53(N) and Flag-tagged constructs 
(constructs e  –  g in C) of Kank were transfected 
in HEK293T cells, and the complex containing 
IRSp53(N) was immunoprecipitated with an 
anti-GFP antibody and analyzed by Western 
blotting using an anti-GFP antibody (the posi-
tions of GFP-IRSp53(N) are indicated by dots; 
top) or an anti-Flag antibody (bottom). The 
GFP expression vector was used as a control 
(v), and the lysate lanes show the expression of 
each plasmid construct (bottom). (E) Interaction 
of the coiled-coil domain of Kank with IRSp53. 
The lysates from the cells expressing the GFP-
tagged coiled-coil domain of Kank (Kank 
coil  ; 
construct h in C) and Flag-IRSp53(N) (construct c 
in A) were immunoprecipitated with preimmune 
serum or with an antibody against GFP or Flag. 
The complex was then analyzed by Western 
blotting. (F) The coiled-coil domain of IRSp53 
does not interact with the coiled-coil domain 
of kinectin. The lysates of the cells expressing 
the GFP-tagged coiled-coil domain of kinectin 
(amino acids 1,116  –  1,356; GFP-kinectin 
coil  ) 
and Flag-IRSp53(N) (construct c in A) were 
immunoprecipitated with control IgG or anti-
bodies against GFP (    -GFP) or Flag (    -Flag). 
The complex was then analyzed by Western 
blotting as indicated. IP, immunoprecipitation; 
WB, Western blot.     JCB • VOLUME 184 • NUMBER 2 • 2009  256
Kank binds to IRSp53 at the coiled-coil domain. This result was 
further verifi  ed by coexpressing Flag-IRSp53(N) (  Fig. 2 A  , con-
struct c) and a GFP-tagged coiled-coil region of Kank (  Fig. 2 C  , 
construct h) in HEK293T cells and by examining reciprocal 
immunoprecipitation followed by Western blotting (  Fig. 2 E  ). 
The specifi  city of the binding was further examined by using a 
coiled-coil domain of kinectin (amino acids 1,116  –  1,356; GFP-
kinectin 
coil  ;   Fig. 2 F  ). In this study, GFP-kinectin 
coil   did not bind 
to Flag-IRSp53(N). Thus, the results indicate that IRSp53 binds 
specifi  cally to Kank through its coiled-coil domain. 
  Kank regulates the binding between active 
Rac1 and IRSp53 
  As reported, active Rac1 binds to IRSp53 through its N-terminal 
229 amino acid residues (  Miki et al., 2000  ;   Miki and Takenawa, 
2002  ), which contain the Kank binding domain, so we tested 
whether Kank can compete against Rac1 in vitro (  Fig. 3, A and B  ). 
Both His-Rac1 
G12V  and His-cdc42 
G12V  bound to GST-IRSp53(N), 
whereas GST alone did not, indicating that IRSp53 binds 
was performed using an anti-Flag antibody (  Fig. 2 B  ). Positive 
GFP signals were observed for the wild-type GFP-IRSp53 
( Fig.  2  A ,  construct a) and GFP-IRSp53(N) (N-terminal part 
containing the IMD/RCB domain and half CRIB domain;  Fig. 2 A , 
construct c). In contrast, a mutant of IRSp53 having a deletion 
at the coiled-coil domain (amino acids 75 – 153; GFP-IRSp53 
   coil ; 
  Fig. 2 A  , construct b), a mutant containing the C-terminal part, 
including the SH3 domain (amino acids 362  –  521; construct d), 
and the GFP-vector (control;   Fig. 2 A  , construct v) did not show 
any signal for GFP in the immunoprecipitates, indicating that 
Kank binds to IRSp53 at its coiled-coil domain. The lanes for 
lysates showed the expression of the individual constructs. Sim-
ilarly, Flag-tagged Kank and its mutants were expressed in 
HEK293T cells along with GFP-IRSp53(N) (  Fig. 2 A  , construct c) 
and were immunoprecipitated with polyclonal anti-GFP anti-
body (  Fig. 2 D  ). Western blotting using an anti-Flag antibody 
showed strong signals for Flag-Kank (  Fig. 2 C  , construct e) and 
Flag-Kank 
   Ank   (  Fig. 2 C  , construct g) but no signal for Flag-
Kank 
   coil   (  Fig. 2 C  , construct f). The result also indicates that 
  Figure 3.       Kank regulates the binding between IRSp53 and 
active Rac1.   (A) Inhibition of binding in vitro of Rac1 (for the 
top Western blots) or cdc42 (for the bottom Western blots) 
with IRSp53 by Kank. Binding between GST-IRSp53(N) 
(lanes 3  –  8) or control GST (lane 1) and His-Rac1 
G12V   or His-
cdc42 
G12V   (lanes 2  –  8) was examined in the presence of MBP-
Kank 
coil   (increasing concentrations; lanes 6  –  8). His-Rac1 
G12V   
(top) and His-cdc42 
G12V   (bottom) used for the experiments 
in lanes 2  –  8 are shown in the last lane (shown as Input). 
(B) Quantiﬁ  ed data of Rac1 and cdc42 bands. The intensity 
of the bands of Rac1 and cdc42 in A was quantiﬁ  ed, and the 
mean   ±   SD of three Western blots for each band is shown. 
Band intensities are measured in arbitrary units. (C) Increased 
binding between IRSp53 and active Rac1 in vivo on KD of 
Kank. Lysates from HEK293 cells stably expressing Rac1 
G12V   
were used for immunoprecipitation (IP) with normal IgG as 
a negative control (lane 1) or with     -IRSp53 (against the C 
terminus) after transfection with control esiRNA (lane 2) or 
with Kank esiRNA (lanes 3 and 4, duplicated). Pull down with 
GST-PAK1 
CRIB  , a cdc42/Rac1-binding domain of PAK1 fused 
to GST, was used for detecting active Rac1 (lane 5). Western 
blots of individual proteins are shown. Immunoprecipitated 
Rac1 and IRSp53 were quantiﬁ  ed, and the relative amount of 
coimmunoprecipitated Rac1 was calculated as the ratio of the 
intensity of Rac1 to that of corresponding immunoprecipitated 
IRSp53 and is shown under the image of anti-Rac1 antibody. 
Black lines indicate that intervening lanes have been spliced 
out. WB, Western blot.     257 KANK IN ACTIN REMODELING   • Roy et al. 
Overexpression of Kank 
S167A  , which lacks the ability to bind to 
14-3-3 and has inhibitory effects on active RhoA and cell mi-
gration (  Kakinuma et al., 2008  ), also impaired the formation of 
lamellipodia induced by Rac1 
G12V   ( Fig.  4  A ,  lane  5).  However, 
Kank 
   coil  , which cannot interact with IRSp53, had no effect on 
the Rac1 
G12V  -induced development of lamellipodia (  Fig. 4 A  , 
lane 6). To confi  rm that this effect of Kank depends on the inter-
action with IRSp53, we performed coexpression of Kank with 
IRSp53 (  Fig. 4 B  ). Coexpression of GFP-Rac1 
G12V   and  Kank 
with IRSp53 resulted in the disappearance of Kank  ’  s inhibitory 
effect on the Rac1 
G12V  -dependent formation of lamellipodia 
(  Fig. 4 B  , lane 4). However, coexpression of GFP-Rac1 
G12V  
and Kank with IRSp53 
R11E/Q23E   or IRSp53 
K143E  , which could 
not bind to Rac1 and could bind to Kank (Fig. S1, available 
at http://www.jcb.org/cgi/content/full/jcb.200805147/DC1; 
  Suetsugu et al., 2006b  ), resulted in the retention of the inhibi-
tory effect on the Rac1 
G12V  -dependent development of lamelli-
podia (  Fig. 4 B  , lanes 5 and 6). This result implies that Kank 
inhibits Rac1  –  IRSp53 signals for the formation of lamellipodia. 
Moreover, to confi  rm that this Rac1 
G12V -dependent  formation 
depends on IRSp53, we performed KD of IRSp53 along with 
GFP-Rac1 
G12V   expression (  Fig. 4 C  ). We fi  rst examined the KD 
of mouse IRSp53 (mIRS) in NIH3T3 cells using various candi-
date plasmids (Fig. S2). These plasmids contained an H1 
promoter  –  based expression system for siRNAs in mammalian 
cells (  Steffen et al., 2004  ). Based on the results, we used #513 
siRNA for the KD of mIRS. Coexpression of GFP-Rac1 
G12V   and 
mIRS-KD reduced the Rac1 
G12V  -dependent formation of lamel-
lipodia (  Fig. 4 C  , lane 3), whereas on the coexpression of human 
IRSp53 with GFP-Rac1 
G12V   and mIRS-KD, GFP-Rac1 
G12V  
retained its function (  Fig. 4 C  , lane 4). However, the coexpres-
sion of human IRSp53 
R11E/Q23E   or IRSp53 
K143E   with  GFP-
Rac1 
G12V  and mIRS-KD had little effect on mIRS-KD ’ s function 
in the Rac1 
G12V  -dependent formation of lamellipodia (  Fig. 4 C  , 
lanes 5 and 6). Therefore, the interaction between IRSp53 and 
active Rac1 is important for lamellipodia to form. These results 
suggest that IRSp53 is one of the targets of Rac1 
G12V   in  the 
Rac1 
G12V  -dependent development of lamellipodia. However, 
overexpression of Kank and Kank 
S167A   had little effect on the 
formation of fi  lopodia induced by a constitutively active form 
of cdc42, cdc42 
G12V   (  Fig. 5  , lanes 3 and 4), which may imply 
that Kank was not involved in the cdc42 
G12V -mediated  forma-
tion of microspikes. 
  Depletion of Kank promotes lamellipodial 
development 
  Based on the fi  nding that Kank bound to IRSp53 and inhibited 
active Rac1-mediated lamellipodial development, as well as re-
ports of IRSp53 as a downstream target of Rac1 (  Miki et al., 
2000  ;   Miki and Takenawa, 2002  ), we examined the effect of 
KD of Kank on the formation of lamellipodia (  Fig. 6  ). NIH3T3 
cells were transfected with a Kank KD vector that targeted 
mouse   Kank   transcripts, a control KD vector, and an mIRS-KD 
as indicated in   Fig. 6  . Because we used plasmids containing a 
  neo-gfp   fusion gene in this assay, transfected cells can be 
stained with an anti-GFP antibody against GFP or can be de-
tected with GFP fl  uorophore. The cells were cultured for 48 h 
to Rac1 or cdc42 (  Fig. 3, A and B  , lanes 2 and 3). When this 
binding was challenged by maltose-binding protein (MBP; a 
control) or MBP-Kank 
coil ,  MBP-Kank 
coil   inhibited the binding 
of GST-IRSp53(N) to His-Rac1 
G12V   in a dose-dependent man-
ner more effi  ciently than the binding of GST-IRSp53(N) to 
His-cdc42 
G12V   (  Fig. 3, A and B  , lanes 6  –  8). MBP alone or MBP-
kinectin 
coil   (containing a control coiled-coil domain) did not af-
fect the binding (  Fig. 3, A and B  , lanes 4 and 5). In   Fig. 2 B  , we 
determined the binding domain of Kank in IRSp53 (amino acids 
80  –  150), which also overlapped with the coiled-coil domain 
and was located within the RCB.   Yamagishi et al. (2004)   re-
ported that the N-terminal half of IRSp53 contains a fi  lopodium-
inducing domain regulated by Rac1 and cdc42. IRSp53 
contains a partial CRIB motif (  Burbelo et al., 1995  ;   Govind 
et al., 2001  ;   Krugmann et al., 2001  ), a sequence of 16 amino 
acid residues (amino acids 267  –  283), which is located far from 
the Kank binding domain (amino acids 80  –  150). Our result 
showed that the binding of Kank to IRSp53 partially affected 
the binding between cdc42 and IRSp53 (  Fig. 3, A and B  ). We 
then examined the effect of knockdown (KD) of Kank using 
endo  ribonuclease-prepared siRNA (esiRNA) on the binding 
between active Rac1 and IRSp53 in vivo (  Fig. 3 C  ). For this, 
we established HEK293 cells stably expressing active Rac1 
(Rac1 
G12V  ). These cells were transfected with Kank esiRNA 
along with control esiRNA. After treatment with esiRNA for 
30 h, the cells were subjected to immunoprecipitation using an 
anti-IRSp53 antibody that was raised against the C-terminal 
portion of IRSp53. The results of Western blot analysis revealed 
that Kank esiRNA effi  ciently decreased the level of Kank pro-
tein in the lysates but did not change the level of IRSp53 or 
Rac1 protein (  Fig. 3 C  , compare lanes 3 and 4 with lanes 1 or 2 
in the lysate panel). The results of immunoprecipitation showed 
that depletion of Kank with Kank esiRNA resulted in less Kank 
(  Fig. 3 C  , compare lanes 3 and 4 with lane 2 in the top row) and, 
at the same time, increased the amount of active Rac1 (Rac1 
G12V ; 
 Fig. 3 C , lanes 2 – 4 in the third row), both of which were immuno-
precipitated with IRSp53. In other words, KD of Kank resulted 
in increased binding between IRSp53 and active Rac1. Normal 
IgG was used as a negative control, and GST-PAK1 
CRIB   was 
used for the pull down of active Rac1 (  Fig. 3 C  , lanes 1 and 5, re-
spectively). From these results, Kank specifi  cally inhibits the 
binding of Rac1 to IRSp53. 
  Kank inhibits Rac1-induced formation 
of lamellipodia through IRSp53 
  Kank affected the interaction between IRSp53 and Rac1 and 
partially affected that between IRSp53 and cdc42 (  Fig. 3  ). This 
led us to investigate the effect of Kank expression on the forma-
tion of lamellipodia or fi  lopodia mediated by Rac1 or cdc42 
(  Figs. 4 and 5  ). Initially, IRSp53 was reported to be a down-
stream target of Rac1 that links Rac1 activity to WAVE/Scar 
and the Arp2/3 complex (  Miki et al., 2000  ;   Etienne-Manneville 
and Hall, 2002  ). However, others reported that IRSp53 prefer-
entially binds to active cdc42 (  Govind et al., 2001  ;   Krugmann 
et al., 2001  ). Overexpression of Kank severely impaired the de-
velopment of lamellipodia and cell spreading induced by a con-
stitutively active form of Rac1, Rac1 
G12V   (  Fig. 4 A  , lane 4). JCB • VOLUME 184 • NUMBER 2 • 2009  258
  Figure 4.       Expression of Kank inhibits lamellipodial development mediated by active Rac1 through IRSp53.   (A) Effect of the expression of Kank on active 
Rac1-induced formation of lamellipodia. NIH3T3 cells were transfected as indicated, treated as described in Materials and methods, and stained for 
GFP (green) and Kank or its mutants (red). The number of cells spreading with lamellipodia is shown on the right as a percentage of the total number of 
transfected cells. *, P   <   0.001 compared with lane 3. (B) Overexpression of IRSp53 abolished the effect of Kank on Rac1 
G12V  -dependent lamellipodial 259 KANK IN ACTIN REMODELING   • Roy et al. 
stimulated cells exhibited extensive membrane ruffl  ing (  Fig. 7  , 
lane 2). When Kank was overexpressed, the number of cells 
with membrane ruffl  ing was signifi  cantly decreased (  Fig. 7  , 
lane 3). However, the effect of overexpression of Kank was 
not observed when IRSp53 was coexpressed (  Fig. 7  , lane 5). 
This result suggests that IRSp53 abrogates the inhibitory 
effect of Kank on insulin-induced membrane ruffl  ing and, 
thus, that Kank inhibits insulin-induced membrane ruffling 
through IRSp53. 
  Kank inhibits integrin-mediated cell 
spreading through IRSp53 
  Integrins are major adhesion receptors in vertebrates and play 
major roles in cell adhesion and in a variety of intracellular signal-
ing pathways (  Hynes, 2002  ). The Rho family of small GTP  ases 
such as Rac1 and cdc42 are involved in integrin-mediated 
cell spreading (  Clark et al., 1998  ;   Price et al., 1998  ;   Katoh and 
Negishi, 2003  ;   Choi et al., 2005  ). As Kank interrupted the inter-
action between active Rac1 and IRSp53 (  Fig. 3  ), we hypothe-
sized that it might inhibit integrin-mediated cell spreading. To 
investigate the role of Kank downstream of integrin signaling, 
NIH3T3 cells were transfected, seeded on fi  bronectin-coated 
glass substrata, fi  xed, and stained with phalloidin (  Fig. 8 A  ). 
The cells adhered rapidly to the substrata and completed spread-
ing in 30 min, showing a normal shape (  Fig. 8 A  , lane 1). How-
ever, the expression of the wild-type Kank radically changed 
cell shape and markedly inhibited cell spreading (  Fig. 8 A  , lane 2). 
Notably, this change was not caused by apoptosis because 
after transfection and fi  xed and stained with anti-GFP antibody 
(  Fig. 6 B  ; green) or with phalloidin (  Fig. 6 B  ; red). Transfection 
of a KD vector (Kank-KD) effectively suppressed the expres-
sion of Kank protein by     80% with respect to control-KD 
(  Fig. 6 A  , lanes 2 and 3), and mIRS-KD suppressed the expres-
sion of mIRS protein by     100% with respect to control-KD 
(  Fig. 6 A  , lanes 3 and 4). A careful observation of cell morphol-
ogy revealed that silencing of Kank resulted in the formation of 
lamellipodia (  Fig. 6 B  , lane 2). However, the silencing of both 
Kank and IRSp53 simultaneously had little effect (  Fig. 6 B  , 
lane 3). These fi  ndings support the idea that Kank inhibits la-
mellipodia from forming by interrupting the interaction be-
tween active Rac1 and IRSp53. 
  Kank inhibits insulin-induced membrane 
rufﬂ  ing 
  Lamellipodia and fi  lopodia are formed at the leading edge in 
migrating cells in response to growth factors, chemokines, 
and extracellular matrix molecules (  Ridley et al., 2003  ). Insu-
lin acts as a growth factor, and insulin-stimulated KB cells, a 
strain derived from human epidermoid carcinoma, show mem-
brane ruffl  ing and Rac1 activation (  Nishiyama et al., 1994  ). 
Overexpression of Kank inhibited active Rac1-dependent la-
mellipodial development (  Fig. 5  ), and KD of Kank enhanced 
the formation of lamellipodia (  Fig. 6  ). We then investigated 
whether Kank can inhibit insulin-induced membrane ruffl  ing 
(  Fig. 7  ). Whereas serum-starved NIH3T3 cells without treat-
ment showed little membrane ruffl  ing (  Fig. 7  , lane 1), insulin-
formation. NIH3T3 cells were transfected as indicated, treated as described in Materials and methods, and stained for Kank (red) and human IRSp53 or its 
mutants (purple). GFP is shown in green. The number of cells spreading with lamellipodia is shown as in A. *, P   <   0.001 compared with lane 1; **, P   <   0.01 
compared with lane 1 or 4. IRS 
R,Q/E  , human IRSp53 with arginine replaced by glutamic acid at position 11 and glutamine replaced by glutamic acid at 
position 23; IRS 
K/E  , human IRSp53 with lysine replaced by glutamic acid at position 143. (C) KD of mIRS (mIRS-KD) decreased Rac1 
G12V  -dependent lamel-
lipodial formation. NIH3T3 cells were transfected as indicated, treated as described in Materials and methods, and stained for GFP (green) and mIRS 
(endogenous) with human IRSp53 (expressing transiently) or its mutants (red). The number of cells spreading with lamellipodia is shown as in A. *, P   <   0.001 
compared with lane 2; **, P   <   0.01 compared with lane 2 or 4. LM, phase-contrast light microscopic image. The results are shown as the mean   ±   SD for 
triplicate experiments in which     100 cells per experiment were counted. Bars, 10   μ  m.     
 
  Figure 5.       Kank has no effect on active cdc42-dependent ﬁ  lopodial development.   The effect of Kank expression on active cdc42-dependent formation of 
ﬁ  lopodia was examined. NIH3T3 cells were transfected as indicated, treated as described in Materials and methods, and stained for GFP (green) and 
Kank or its mutants (red). The number of cells spreading with ﬁ  lopodia is shown on the right as a percentage of the total number of transfected cells. The 
results are shown as the mean   ±   SD for triplicate experiments in which     100 cells per experiment were counted. LM, phase-contrast light microscopic 
image. Bar, 10   μ  m.     JCB • VOLUME 184 • NUMBER 2 • 2009  260
  Rac1 signaling. Kank was coexpressed with IRSp53 
R11E/Q23E  
or IRSp53 
K143E   in NIH3T3 cells when the cells were spread-
ing (  Fig. 8 B  , lanes 4 and 5). Surprisingly, the rates of spread-
ing differed little between wild-type IRSp53, IRSp53 
R11E/Q23E , 
and IRSp53 
K143E   when Kank was present (  Fig. 8 B  , lanes 3  –  5). 
Next, we investigated whether IRSp53 was involved in the 
spreading of NIH3T3 cells (  Fig. 8 C  ). KD of mIRS resulted in 
the inhibition of cell spreading (  Fig. 8 C  , compare lane 1 with 
lane 3). In contrast, KD of mIRS with overexpression of the wild 
type or the mutants of human IRSp53 did not affect the spread-
ing of NIH3T3 cells (  Fig. 8 C  , lanes 4  –  6). Furthermore, there 
was almost no change in cell spreading with or without KD of 
IRSp53 when Kank was overexpressed (Fig. S3, available at 
http://www.jcb.org/cgi/content/full/jcb.200805147/DC1). 
 We then investigated the effect of Kank and IRSp53 expres-
sion on cell morphology when NIH3T3 cells were spreading 
upon stimulation with fi  bronectin (Fig. S4, available at http://
www.jcb.org/cgi/content/full/jcb.200805147/DC1). Cell shapes 
were classifi  ed according to those in the process of matrix-based 
cell spreading (  Applewhite et al., 2007  ). Overexpression of Kank 
nuclear staining of transfected cells with DAPI did not show 
any sign of apoptosis (unpublished data) and the cells were via-
ble, as they could spread later (unpublished data). Kank 
   coil , 
which cannot bind to IRSp53, did not show any signifi  cant 
changes in cell shape or cell spreading (  Fig. 8 A  , lane 3). 
Kank 
S167A  , which cannot bind to 14-3-3, partially inhibited cell 
spreading (  Fig. 8 A  , lane 4). We obtained similar results using 
COS-7 and HeLa cells (unpublished data). In contrast, a control 
protein with the coiled-coil domain, kinectin 
coil  , did not affect 
the spreading of NIH3T3 cells (  Fig. 8 A  , lane 5). From these 
results, Kank inhibits cell spreading specifi  cally through its 
coiled-coil domain. 
  To see how Kank inhibits cell spreading and whether 
this phenomenon depends on IRSp53, Kank was coexpressed 
with IRSp53 in NIH3T3 cells (  Fig. 8 B  ). When Kank was co-
expressed with wild-type IRSp53, cell spreading was enhanced 
compared with that when only Kank was expressed (  Fig. 8 B  , 
compare lane 2 with lane 3). Integrin activates Rac1 and cdc42 
( Price et al., 1998 ;  Hynes, 2002 ). We then examined whether the 
inhibitory effect of Kank on cell spreading depends on IRSp53  –
  Figure 6.       Deletion of Kank signiﬁ  cantly increases lamellipodial development through IRSp53.   (A) Relative expression of Kank and IRSp53 in NIH3T3 cells 
expressing RNAi. The levels of expression of Kank and mIRS relative to the amount of actin in the cell lysates were analyzed by Western blotting and quan-
tiﬁ  ed. (B) Confocal laser microscopic images of NIH3T3 cells transfected with Kank-KD and/or IRSp53-KD constructs. pSUPER.neo+gfp constructs were 
transfected, and the cells were ﬁ  xed and stained with anti-GFP antibody (green) and phalloidin (red). Transfected cells were indicated as GFP-expressing 
cells, which were likely to show KD of the protein as indicated. Kank-KD  –  dependent lamellipodial extension was magniﬁ  ed in the bottom panel (lane 2). 
Quantiﬁ  cation of lamellipodia in NIH3T3 cells expressing Kank-KD and/or IRSp53-KD is summarized in a graph. The results are shown as the mean   ±   SD 
for three independent experiments in which     100 cells were counted in each experiment. *, P   <   0.001 compared with lane 1. Bar, 10   μ  m.     261 KANK IN ACTIN REMODELING   • Roy et al. 
demonstrate that Kank is involved in the IRSp53-mediated 
formation of neurites. 
  Discussion 
  In this study, we demonstrated that Kank plays a major role in the 
negative regulation of lamellipodial development in fi  broblasts. 
The regulation is likely to be mediated by interaction with IRSp53 
in ruffl  ed areas of the cell. This binding seems to be constitutive 
because it was not affected by stimulation with a growth factor 
like PDGF or EGF (unpublished data). IRSp53 is a multidomain 
scaffolding protein (  Govind et al., 2001  ;   Krugmann et al., 2001  ; 
  Soltau et al., 2002  ,   2004  ;   Funato et al., 2004  ;   Choi et al., 2005  ; 
  Connolly et al., 2005  ;   Hori et al., 2005  ) and a downstream tar-
get of Rac1 and links WAVE2 to Rac1 (  Miki et al., 2000  ;   Miki 
and Takenawa, 2002  ), which plays an important role in the re-
organization of the actin cytoskeleton. 
  Kank contains two important domains, the coiled-coil and 
ankyrin repeat domains, both of which have been described in 
several structural proteins as well as in proteins involved in an 
array of cellular functions (  Sedgwick and Smerdon, 1999  ; 
  Burkhard et al., 2001  ). We showed in this study that the coiled-
coil domain of Kank is necessary for binding with IRSp53 and 
the negative regulation of cell spreading and lamellipodial de-
velopment induced by constitutively active Rac1 (  Fig. 4  ). 
  Although active Rac1- or active cdc42-dependent actin 
polymerization has been described for the regulation of WASP 
and WAVE proteins (  Bompard and Caron, 2004  ) and the regula-
tion of Rac1 activity through three major classes of regulators, 
GTPase-activating proteins, guanine nucleotide exchange fac-
tors, and GDP dissociation inhibitors, has been identifi  ed, albeit 
with little understanding of the signaling pathways that modu-
late their activity (  Burridge and Wennerberg, 2004  ), Kank does 
not possess any of these classical regulatory functions in Rac1 
activation. This raises the possibility that Kank functions via 
other proteins also. 
decreased the number of cells with the fi  lopodial phenotype, 
whereas overexpression of IRSp53 increased the number of 
smooth-edged cells. Notably, coexpression of Kank and IRSp53 
decreased the number of cells with the fi  lopodial phenotype, 
whereas there was no increase in the number of the cells with 
the smooth-edged phenotype. These results suggest that Kank 
partially inhibits the spreading of NIH3T3 cells through IRSp53, 
although this phenomenon was not part of the Rac1  –  IRSp53 
signaling pathway. The reason why IRSp53 partially recovers 
cell spreading inhibited by Kank might be that Kank inhibits the 
formation of both fi   lopodial microspikes and lamellipodial 
sheets, whereas IRSp53 contributes only to lamellipodial sheets 
when the cells are spreading. 
  Kank inhibits IRSp53-mediated neurite 
outgrowth in N1E115 cells 
  Ectopic expression of IRSp53 in mouse neuroblastoma 
N1E115 cells induces neurite outgrowth (  Govind et al., 2001  ; 
  Miki and Takenawa, 2002  ), with Rac1 and cdc42 acting as 
positive regulators and Rho inhibiting the process (  Kozma 
et al., 1995  ,   1997  ;   Luo, 2000  ). To assess whether Kank is also 
involved in IRSp53-mediated neurite outgrowth, N1E115 cells 
were transfected with GFP-tagged IRSp53 to reproduce the 
morphological changes described previously (  Govind et al., 
2001  ). Overexpression of GFP-Kank inhibited neurite out-
growth under serum starvation (  Fig. 9 A  ). The cells transfected 
with GFP-IRSp53 showed vigorous neuritic development in 
the presence or absence of serum (  Fig. 9 B  , second row). There 
were no round or adherent neurites when the cells were not 
transfected in the presence of serum. When Kank was co-
expressed with GFP-IRSp53, the cells showed a phenotype simi-
lar to that seen with GFP alone (  Fig. 9 B  , bottom, Serum [+]). 
The quantitative analysis showed that Kank signifi  cantly re-
duced the extent of the IRSp53-induced outgrowth of neurites 
both in the presence (from 40 to 14%) and in the absence 
(from 85 to 25%) of serum (  Fig. 9 B  , graph). These fi  ndings 
  Figure 7.       Kank inhibits insulin-induced membrane rufﬂ  ing.   The effect of Kank on insulin-induced membrane rufﬂ  ing in NIH3T3 cells was examined. The 
cells were transfected and treated as described in Materials and methods. The images were obtained by confocal laser microscopy. The number of cells 
with membrane rufﬂ  ing is shown on the right as a percentage of the total number of transfected cells. The results are shown as the mean   ±   SD for triplicate 
experiments in which 100 cells per experiment were counted. *, P   <   0.001 compared with lane 2. Bar, 10   μ  m.     JCB • VOLUME 184 • NUMBER 2 • 2009  262
form a complex with Abi-1, Sos-1, E3B1, and PI3-K, which 
activate Rac1 and transduce signals from Ras to Rac1 ( Biesova 
et al., 1997  ;   Scita et al., 1999  ,   2001  ;   Innocenti et al., 2003  ). 
Tiam1, another Rac1 activator, also binds to IRSp53, leading 
to increased activation of Rac1 and enhanced binding of 
IRSp53 to both active Rac1 and WAVE2. Tiam1 promotes the 
  IRSp53 makes a complex with Eps8 and activates Rac1, 
which is important to cancer cell motility and invasion (  Funato 
et al., 2004  ). Active cdc42 binds to the complex of IRSp53 
and Eps8 and controls its cellular distribution, thereby con-
tributing to the generation of actin bundles and promoting fi  lo-
podial protrusions (  Disanza et al., 2006  ). Eps8 was shown to 
  Figure 8.       Kank inhibits integrin-dependent cell spreading through IRSp53  . (A) Effect of Kank expression on cell spreading. NIH3T3 cells were transfected 
as indicated and treated as described in Materials and methods. The cells were then stained for GFP (green). The number of spreading cells is shown on 
the right as a percentage of the total number of transfected cells. *, P   <   0.001 compared with lane 1. (B) Overexpression of IRSp53 partially abolished 
the effect of Kank on the spreading of NIH3T3 cells. The cells were transfected as indicated and treated as described in Materials and methods. The cells 
were stained for GFP (green) and IRSp53 or its mutants (red). The number of spreading cells was counted as in A. *, P   <   0.001 compared with lane 1; 
**, P   <   0.001 compared with lane 1 or 2. (C) Integrin-dependent cell spreading was mediated by IRSp53 in NIH3T3 cells. pSUPER.neo+gfp constructs 
were transfected with or without IRSp53 or its mutants as indicated. The cells were treated as described in Materials and methods and were stained for GFP 
(green) and IRSp53 or its mutants (red). The number of spreading cells was counted as in A. *, P   <   0.001 compared with lane 1. mIRS-KD, IRS 
R,Q/E  , and 
IRS 
K/E   are described in   Fig. 4 (B and C)  . LM, phase-contrast light microscopic image. The results are shown as the mean   ±   SD for triplicate experiments in 
which     100 cells per experiment were counted. Bars, 10   μ  m.     263 KANK IN ACTIN REMODELING   • Roy et al. 
NIH3T3 cells showed marked differences: the formation of 
lamellipodia induced by active Rac1 was inhibited (  Fig. 4  ), 
whereas microspikes or fi  lopodia generated by active cdc42 
showed some but not great alteration (  Fig. 5  ). Because the 
IMD/RCB domain of IRSp53 overlaps with the Kank binding 
domain, Kank might disrupt the association of active Rac1 to 
localization of IRSp53 to Rac1-induced lamellipodia rather 
than cdc42-induced fi  lopodia (  Connolly et al., 2005  ). Simi-
larly, Kank specifi  cally inhibits the binding between IRSp53 
and Rac1 
G12V   rather than that between IRSp53 and cdc42 
G12V  
(  Fig. 3, A and B  ), which is consistent with the fi  nding that the 
coexpression of Kank with active Rac1 or active cdc42 in 
  Figure 9.       Kank inhibits IRSp53-mediated neurite out-
growth in N1E115 cells.   (A) Suppression of neurite out-
growth by Kank in N1E115 cells. Fluorescence images 
were obtained for N1E115 cells expressing GFP alone or 
GFP-tagged Kank in the presence (left) or absence (right) 
of serum. The quantiﬁ   cation of different phenotypes of 
N1E115 cells is summarized in a graph. *, P   <   0.001 
compared with GFP-expressing cells with the same mor-
phology. (B) Suppression of IRSp53-mediated neurite out-
growth by Kank in N1E115 cells. Fluorescence images 
were obtained for N1E115 cells expressing GFP alone, 
GFP-tagged IRSp53 (IRSp53), or GFP-IRSp53 with co-
expression of Kank (IRSp53 + Kank). The effect of the 
transient expression of GFP alone (top), GFP-IRSp53 
(middle), or GFP-IRSp53 with Kank (bottom) in N1E115 
cells in the presence (left) or absence (right) of serum. The 
quantiﬁ  cation of different phenotypes of N1E115 cells is 
summarized in a graph. *, P   <   0.001; **, P   <   0.01; ***, 
P   <   0.05 compared with GFP-expressing cells with the 
same morphology. LM, phase-contrast light microscopic 
image. The results are shown as the mean   ±   SD for three 
independent experiments in which     100 transfected cells 
were counted. Bars, 10   μ  m.     JCB • VOLUME 184 • NUMBER 2 • 2009  264
the Kank  –  IRSp53 complex in response to external stimuli, 
which may contribute to our understanding of the cell signaling 
mechanisms in renal cell carcinoma. 
  Materials and methods 
  Expression vectors and antibodies 
  Cytomegalovirus-driven Flag-tagged constructs (Agilent Technologies), GFP-
tagged constructs (BD), the vector pcDNA-3.1 (Invitrogen), the hEF1-      –
  driven expression vector pEF1/myc-His (Invitrogen), and a bacterial 
ex  pression vector for GST, pGEX-5x-1(GE Healthcare), were generated by 
recombinant PCR. Full-length human IRSp53 cDNA was obtained by RT-PCR. 
Kank mutants and human IRSp53 mutants were made by PCR-mediated re-
combination. The coiled-coil domain of kinectin (kinectin 
coil  ) was obtained 
by RT-PCR and used as a control (  Vignal et al., 2001  ). All of the constructs 
were veriﬁ   ed by sequencing. Polyclonal and monoclonal antibodies 
against Kank were described previously (  Sarkar et al., 2002  ;   Roy et al., 
2005  ). The polyclonal antibody against mouse Kank recognizes a peptide 
spanning amino acids 861  –  975 (  Kakinuma et al., 2008  ). The polyclonal 
antibody against IRSp53 was a gift from M. Yamada (National Research 
Institute for Child Health and Development, Tokyo, Japan;   Okamura-Oho 
et al., 1999  ) or was generated in a rabbit using the C-terminal part of the 
protein (163 residues long, amino acids 358  –  521) fused to GST as an an-
tigen and was prepared by afﬁ  nity puriﬁ  cation. A monoclonal antibody 
against autoﬂ   uorescent proteins (MP Biomedicals), a rabbit antiserum 
against GFP (Invitrogen), a polyclonal antibody against GFP (Clontech 
Laboratories, Inc.), a monoclonal antibody against cdc42 protein, a poly-
clonal antibody against EGF receptor (Santa Cruz Biotechnology, Inc.), a 
monoclonal antibody against Rac1 (Transduction Laboratories), a goat 
polyclonal antibody against WAVE2 (Santa Cruz Biotechnology, Inc.), and 
monoclonal antibodies against Flag, GFP,     -actin, and     -tubulin (Sigma-
Aldrich) were purchased. 
  Cell culture, immunoprecipitation, and immunoblotting 
  HEK293 cells stably expressing Rac1 
G12V   were constructed with the 
pcDNA4/TO expression vector (Invitrogen). NIH3T3, HeLa, N1E115 
(a gift from Y. Kanaho, Tsukuba University, Ibaraki, Japan), HEK293 (a 
gift from M. Noguchi, Hokkaido University, Hokkaido, Japan), and 
HEK293T cells were cultured in DME supplemented with 10% FBS. 
VMRC-RCW cells were cultured in MEM with 10% FBS. Transfection was 
performed using Lipofectamine 2000 (Invitrogen) and Effectine (QIAGEN) 
according to the manufacturers  ’   instructions. After 30 h, cells were har-
vested, washed with ice-cold PBS, and lysed for 15 min on ice in buffer 
A (50 mM Tris-HCl, pH 7.5, 140 mM NaCl, 10% glycerol, 1% Nonidet 
P-40, 100 mM NaF, 200 mM Na  3  VO  4  , 1 mM PMSF, 10   μ  g/ml leupeptin, 
10   μ  g/ml aprotinin, and 10   μ  g/ml chymotrypsin). The cell lysates were 
clariﬁ  ed by centrifugation, and the proteins were immunoprecipitated, 
washed in the lysis buffer, and boiled in an SDS-PAGE loading buffer. 
Proteins were separated by SDS-PAGE, transferred to polyvinylidene 
diﬂ  uoride membranes (Immobilon; Millipore), and detected with respec-
tive antibodies. Signals were enhanced with secondary antibody against 
AP (Sigma-Aldrich) or HRP (GE Healthcare) and developed with nitroblue 
tetrazolium/5-bromo-4-chloro-3-indolyl phosphate (Sigma-Aldrich) or ECL 
(GE Healthcare). The intensity of the bands was quantiﬁ  ed by ImageJ 
software (National Institutes of Health). 
  Immunocytochemistry 
  The cells on coverslips were ﬁ  xed with 3.7% formaldehyde-PBS for 30 min 
and permeabilized with 0.25% Triton X-100  –  PBS for 10 min. The cells 
were subsequently incubated with the primary and secondary antibodies. 
The secondary antibodies used were Alexa Fluor 594  –  conjugated goat 
anti  –  mouse and anti  –  rabbit IgG (Invitrogen), Alexa Fluor 488  –  conjugated 
goat anti  –  mouse and anti  –  rabbit IgG (Invitrogen), RITC-conjugated don-
key anti  –  goat IgG (Santa Cruz Biotechnology, Inc.), and Cy5-conjugated 
goat anti  –  rabbit IgG (Millipore). Filamentous actin (F-actin) was stained 
with TRITC-conjugated phalloidin (Sigma-Aldrich). Images of cells after 
they were mounted were acquired at room temperature in 80% (wt/vol) 
glycerol in PBS using AxioVision 3.1 software (Carl Zeiss, Inc.) and a ﬂ  uor-
escence microscope (Axioskop 2 Plus; Carl Zeiss, Inc.) with a Plan-NEO-
FLUAR 40  ×   NA 0.75 objective (Carl Zeiss, Inc.) and a color camera 
(AxioCam HRc; Carl Zeiss, Inc.). Confocal laser microscopy was per-
formed using a laser-scanning confocal microscope (Axiovert 200M; 
Carl Zeiss, Inc.) with LSM510 META software (Carl Zeiss, Inc.). Optical 
thickness was set at 1.0   μ  m in Z height with a Plan-Apochromat 63  ×   NA 
IRSp53. In contrast, the cdc42-binding domain of IRSp53 is 
located far from the Kank binding domain. This may be why 
Kank weakly inhibits cdc42-IRSp53 association. KD of Kank 
by RNAi in NIH3T3 cells revealed that depletion of Kank re-
sulted in an increase in lamellipodia, whereas KD of both 
Kank and IRSp53 resulted in normal or unaltered cell shapes 
(  Fig. 6 B  ). Moreover, Kank inhibited insulin-induced mem-
brane ruffl  ing, and coexpression of Kank with IRSp53 abro-
gated this inhibitory effect (  Fig. 7  ). This suggests that Kank 
inhibits the IRSp53-dependent formation of lamellipodia. 
However, Kank inhibited integrin-dependent cell spreading 
through IRSp53, but this was not caused by Rac1 (  Fig. 8, 
B and C  ). Kank also inhibited IRSp53-dependent neurite out-
growth in N1E115 (  Fig. 9  ). Kank binds to the IMD/RCB do-
main of IRSp53, and it has been shown that this domain binds 
not only to active Rac1 but also to actin and lipids (  Miki et al., 
2000  ;   Yamagishi et al., 2004  ;   Millard et al., 2005  ;   Suetsugu 
et al., 2006b  ). The IMD/RCB domain was also shown to have 
actin-bundling activity (  Millard et al., 2005  ), although this ac-
tivity may only be seen under nonphysiological conditions 
such as at a low ionic strength (  Lee et al., 2007  ;   Mattila et al., 
2007  ). Consistent with this, we also found that actin was pres-
ent in a complex immunoprecipitated with an anti-IRSp53 
antibody in HEK293 cells (Fig. S5, available at http://www
.jcb.org/cgi/content/full/jcb.200805147/DC1). Expression of 
Kank is likely to inhibit the association of IRSp53 with actin, 
which implies that Kank negatively regulates the association 
of IRSp53 with actin. This might be why Kank inhibits the 
spreading of NIH3T3 cells and the outgrowth of neurites in 
N1E115 cells through the binding of IRSp53. 
  Kank regulates RhoA activity through its 14-3-3 binding 
motif inside the coiled-coil domain (  Kakinuma et al., 2008  ). 
Kank inhibited Rac1  –  IRSp53 signaling, which is mediated by 
the coiled-coil domain (  Fig. 4  ). However, the formation of la-
mellipodia induced by active Rac1 was inhibited by both Kank 
and Kank 
S167A  , which cannot bind to 14-3-3 and was ineffective 
against active RhoA (  Fig. 4 A  , lanes 4 and 5). From this fi  nding, 
the effect of Kank on active Rac1-induced lamellipodial devel-
opment can be separated from the effect of the binding of 14-3-3 
to Kank. In contrast, overexpression of Kank 
S167A   was relatively 
ineffective compared with the effect of wild-type Kank on 
integrin-dependent cell spreading (  Fig. 8 A  , compare lane 2 
with lane 4). A deletion mutant, Kank 
   coil  , was not completely 
effective against integrin-dependent cell spreading (  Fig. 8 A  , 
lane 3); Kank may affect the integrin-dependent cell spreading 
mediated by both IRSp53 and 14-3-3 or more likely through the 
Kank coiled-coil domain. 
  Although there are orthologues of Kank in different spe-
cies, in which the coiled-coil domain along with the ankyrin re-
peat domain are conserved, only VAB-19 of   C. elegans   has been 
studied and was shown to be a component of the epidermal at-
tachment structure and to interact with actin (  Ding et al., 2003  ). 
This further strengthens our fi  nding that Kank functions through 
the coiled-coil domain in the regulation of actin remodeling. 
This function of Kank in the reorganization of the actin cyto-
skeleton may be conserved in other orthologues as well. Further 
studies are needed to explore other potential roles of Kank or 265 KANK IN ACTIN REMODELING   • Roy et al. 
detached with trypsin/EDTA, washed with PBS, suspended at     10 
6   cells/ml 
in PBS, and subjected to electroporation. Electroporation was performed 
with 18   μ  g of plasmid DNA using a Gene Pulser II System (Bio-Rad Labora-
tories) at 270 mV and 975-  μ  F capacitance. Under these conditions, we esti-
mated the transfection efﬁ  ciency to be around 50  –  70% by comparing the 
level of expression of GFP in a parallel experiment. After electroporation, 
the cells were kept on ice for 5 min and transferred to plates with 10 ml of 
a complete medium. After 36 h, the cells were lysed in a lysis buffer for 
checking the expression of Kank protein. Kank esiRNA was prepared as 
described previously (  Yang et al., 2002  ;   Kittler et al., 2004  ). In brief, sense 
and antisense RNA was transcribed using a T7 promoter system (for both 
strands) supplied in the MEGAscript kit (Applied Biosystems). After anneal-
ing the sense and antisense strands, RNA was treated with ShortCut RNase III 
(New England Biolabs, Inc.) and puriﬁ  ed with Sepharose Q (GE Health-
care). Kank esiRNA and control esiRNA containing the   Xenopus laevis   
elongation factor gene (from the MEGAscript kit) were transfected with 
Lipofectamine 2000 in HEK293 cells stably expressing Rac1 
G12V  . 
  In vitro binding assay 
  1   μ  g His-Rac1 
G12V   or His-cdc42 
G12V  , which was produced in bacteria and 
puriﬁ  ed with an Ni column, was added with 2   μ  g of control GST or GST-
IRSp53(N) and 10   μ  g MBP or 1, 3, or 10   μ  g MBP-Kank 
coil   as competitor in 
binding buffer A. After these mixtures were rotated for 1 h at 4  °  C, glutathione  –
  Sepharose 4B (GE Healthcare) was added to recover the protein complexes, 
and rotation was continued for 1 h at 4  °  C. The complexes were washed 
four times with the binding buffer, boiled for 5 min in an SDS-PAGE loading 
buffer, and subjected to 5  –  20% SDS-PAGE, Coomassie blue staining, and 
Western blot analysis using anti-Rac1 or anti-cdc42 antibodies to detect the 
respective proteins. The intensity of the bands was quantiﬁ  ed by CS Ana-
lyzer (ATTO Corp.). 
  Online supplemental material 
  Fig. S1 shows IRSp53 mutants that bind to Kank 
coil   but not to Rac1 
G12V  . 
Fig. S2 shows the candidate sequences for IRSp53 KD. Fig. S3 shows that 
KD of IRSp53 does not affect ﬁ   bronectin-stimulated cell spreading when 
Kank is overexpressed. Fig. S4 shows that Kank inhibits the formation of the 
cells with ﬁ  lopodial- and IRSp53-induced smooth-edged phenotypes when 
cells are spreading. Fig. S5 shows that overexpression of Kank inhibits the 
association of IRSp53 with actin. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200805147/DC1. 
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